🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

11+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 11 of 11 recruiting trials for “Von Willebrand disease”

RecruitingNCT07404644 ↗

An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)

👨‍⚕️ Study Director, Takeda📍 1 site📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07115004 ↗

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

🏥 Vega Therapeutics, Inc📍 4 sites📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT07129343 ↗

A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)

👨‍⚕️ Study Director, Takeda📍 7 sites📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT06998524 ↗

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 27 sites📅 Started Jun 2025View details ↗
RecruitingNCT06883240 ↗

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 27 sites📅 Started Apr 2025View details ↗
Phase 3RecruitingNCT05582993 ↗

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

👨‍⚕️ Study Director, Takeda📍 15 sites📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06205095 ↗

A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD

🏥 Unity Health Toronto📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT05776069 ↗

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

🏥 Vega Therapeutics, Inc📍 25 sites📅 Started Mar 2023View details ↗
RecruitingNCT03773159 ↗

Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions

🏥 Centre Hospitalier Universitaire Dijon📍 2 sites📅 Started May 2019View details ↗
Phase 3RecruitingNCT02932618 ↗

A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

👨‍⚕️ Study Director, Takeda📍 46 sites📅 Started Nov 2017View details ↗
Phase 4RecruitingNCT02472665 ↗

Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease

🏥 Grifols Therapeutics LLC📍 4 sites📅 Started Dec 2013View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →